GT20029 is an experimental topical treatment for male-pattern hair loss, showing promising results in Phase 2 trials and moving towards Phase 3. It aims to degrade androgen receptors in hair follicles, differing from treatments like finasteride and minoxidil.
A 25-year-old is experiencing hair thinning despite using 0.5mg oral dutasteride, 0.3% topical finasteride, and 6% topical minoxidil daily for a year. They are considering increasing dutasteride dosage and exploring other treatments like microneedling and KX 826, while seeking further medical opinions on their condition.
The user experienced significant hair regrowth after three months using a topical combination of minoxidil and dutasteride. They reported no side effects and were surprised by the progress, despite initial skepticism.
A 20-year-old used finasteride for 5 months, then switched to dutasteride for 7 months, and added oral minoxidil for 2.5 months, finding the combination of dutasteride and oral minoxidil most effective. The user experienced significant hair improvement and confidence boost, with no blood tests but an ECG to monitor heart health.
A user is seeking advice on a new topical hair loss treatment containing Minoxidil 3%, Finasteride 0.3%, Progesterone 1%, Hydrocortisone butyrate 0.1%, and Ketoconazole 0.5%. They are concerned about the systemic absorption of Finasteride and plan to do blood tests and a spermiogram before starting.
RU58841 and Minoxidil can cause heart-related side effects like chest pain and heart racing. Pyrilutamide is suggested as a safer alternative, though it's new and costly.
User shared progress pictures showing significant hair regrowth using a compounded solution of Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Latanoprost 0.005%. They reported no side effects and are satisfied with the results.
Stemoxydine is no longer available on Amazon in the US, and users discuss alternatives for making topical finasteride. OP cannot use minoxidil due to side effects and seeks other solutions.
The user shared a 3-month progress update on hair loss treatment using oral finasteride, oral minoxidil, dutasteride, ketoconazole, biotin, collagen shampoo, dermarolling, and scalp massage, noting some side effects like decreased libido and low mood. The user received feedback and questions about their regimen, including why both finasteride and dutasteride are used.
A 37-year-old is using topical Minoxidil once daily to address hair thinning, avoiding finasteride due to regular blood donations. They are satisfied with the results, seeing new hair growth, and prioritize blood donation over additional treatments.
The user experienced hair regrowth using dutasteride daily, microneedling weekly, and Nizoral shampoo, after stopping minoxidil due to side effects. They also use a mix of pumpkin seed, rosemary, and peppermint oil, and are considering RU58841 for more temple area thickness.
The user experienced significant hair regrowth using a topical finasteride and minoxidil cream from Essential Clinic in Canada, and plans to switch to dutasteride and undergo a hair transplant in Mexico. They started treatment three months ago and have seen impressive results without side effects, using half the recommended dosage to extend the product's duration.
The user is unsatisfied with their hair transplant and is considering another transplant, PRP, exosomes, or stem cells. They currently use topical minoxidil, dutasteride, and tretinoin.
The conversation is about a topical spray containing finasteride, minoxidil, and tretinoin, with users discussing its effectiveness compared to more established brands. One user mentions using a product with 5% minoxidil, 0.15% finasteride, and 0.15% tretinoin.
The user is considering a crown transplant but is advised to try topical finasteride or dutasteride alongside minoxidil first, as transplants without these treatments may not be effective. They experienced lower libido with oral finasteride and are exploring other options like topical treatments and red light therapy.
The user has been on dutasteride for 20 months with worsening hair loss and is considering switching back to finasteride, which previously stabilized their hair. They are using a regimen including dutasteride, oral and topical minoxidil, vitamins, and ketoconazole shampoo, and are planning to add microneedling.
The conversation is about hair loss treatment progress using dutasteride 0.5mg and oral minoxidil 3mg. Suggestions include adding topical minoxidil with tretinoin and considering micro needling or micro stamping for further improvement.
The conversation is about finding a source for topical valproic acid for hair regrowth. The user mentions PP405 and the unavailability of products from certain suppliers.
Dutasteride significantly improved hair thickness and regrowth for users, often more effectively than finasteride alone. Many users experienced positive results with a combination of dutasteride, finasteride, and oral minoxidil, with minimal side effects.
A 33-year-old male restarted finasteride after stopping it to conceive, noticing hair loss, especially in the crown area. His current routine includes finasteride, minoxidil, ketoconazole, and microneedling, and he plans to continue this treatment for 18 months before making any major changes.
The user switched from topical minoxidil and finasteride to oral minoxidil and dutasteride, noticing hair regrowth and reduced hair loss after 75 days. They experienced slight body hair increase and initial pulse elevation, but no significant side effects.
A user is concerned that prolonged use of valisone (betamethasone) and clotrimazole solution for scalp dermatitis may be causing hair thinning and loss. They noticed thinning in the area where the solution was applied.
The user has been using finasteride and minoxidil for 11 months but experienced hair thinning after adding topical dutasteride. They plan to continue with Lipogaine, finasteride, and a reduced frequency of topical dutasteride, along with dermarolling and biotin.
The conversation discusses hair loss treatments, specifically mentioning pyrilutamide, minoxidil, and finasteride. The consensus suggests starting treatment early, with finasteride being a preferred option.
Delayed release oral minoxidil is seen as a promising advancement for hair loss treatment, offering safer, higher doses and more consistent hair follicle stimulation compared to current options. However, it is not expected to replace finasteride or dutasteride, as it does not prevent androgenetic alopecia.
ABS-201, a prolactin receptor blocker, shows promise in reversing hair loss and graying, with early success in macaques. Current treatments like finasteride, minoxidil, and RU58841 are still widely used, but new options like PP405 are eagerly anticipated.
Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.